225 related articles for article (PubMed ID: 11769675)
21. Fluorescence in situ hybridization improves the detection of monosomy 7 in myelodysplastic syndromes.
Flactif M; Lai JL; Preudhomme C; Fenaux P
Leukemia; 1994 Jun; 8(6):1012-8. PubMed ID: 8207974
[TBL] [Abstract][Full Text] [Related]
22. Delineation by molecular cytogenetics of 5q deletion breakpoints in myelodyplastic syndromes and acute myeloid leukemia.
Royer-Pokora B; Trost D; Müller N; Hildebrandt B; Germing U; Beier M
Cancer Genet Cytogenet; 2006 May; 167(1):66-9. PubMed ID: 16682289
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of chromosome 5 aberrations in complex karyotypes of patients with myeloid disorders reveals their contribution to dicentric and tricentric chromosomes, resulting in the loss of critical 5q regions.
Herry A; Douet-Guilbert N; Morel F; Le Bris MJ; Morice P; Abgrall JF; Berthou C; De Braekeleer M
Cancer Genet Cytogenet; 2007 Jun; 175(2):125-31. PubMed ID: 17556068
[TBL] [Abstract][Full Text] [Related]
24. Myelodysplastic syndromes with del(5q): indications and strategies for cytogenetic testing.
Haferlach C; Bacher U; Tiu R; Maciejewski JP; List A
Cancer Genet Cytogenet; 2008 Dec; 187(2):101-11. PubMed ID: 19027491
[TBL] [Abstract][Full Text] [Related]
25. Fluorescence in situ hybridization analysis of 110 hematopoietic disorders with chromosome 5 abnormalities: do de novo and therapy-related myelodysplastic syndrome-acute myeloid leukemia actually differ?
Lessard M; Hélias C; Struski S; Perrusson N; Uettwiller F; Mozziconacci MJ; Lafage-Pochitaloff M; Dastugue N; Terré C; Brizard F; Cornillet-Lefebvre P; Mugneret F; Barin C; Herry A; Luquet I; Desangles F; Michaux L; Verellen-Dumoulin C; Perrot C; Van den Akker J; Lespinasse J; Eclache V; Berger R;
Cancer Genet Cytogenet; 2007 Jul; 176(1):1-21. PubMed ID: 17574959
[TBL] [Abstract][Full Text] [Related]
26. Redefining monosomy 5 by molecular cytogenetics in 23 patients with MDS/AML.
Herry A; Douet-Guilbert N; Morel F; Le Bris MJ; De Braekeleer M
Eur J Haematol; 2007 Jun; 78(6):457-67. PubMed ID: 17391336
[TBL] [Abstract][Full Text] [Related]
27. Tetraploidy and 5q deletion in myelodysplastic syndrome: a case report.
Znoyko I; Stuart RK; Ellingham T; Winters J; Wolff DJ; Quigley DI
Cancer Genet Cytogenet; 2008 May; 183(1):64-8. PubMed ID: 18474300
[TBL] [Abstract][Full Text] [Related]
28. [Detection of abnormal numbers of chromosome 8 with interphase fluorescence in situ hybridization in hematologic malignancies].
Wang HP; Li GX; Qiao ZH; Wang HW
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Aug; 21(4):395-7. PubMed ID: 15300644
[TBL] [Abstract][Full Text] [Related]
29. [Analysis the clinic and cytogenetics of myelodysplastic syndrome].
Cen L; Zhou M; Zhao YH
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Dec; 23(6):668-9. PubMed ID: 17160950
[TBL] [Abstract][Full Text] [Related]
30. Fluorescence in situ hybridization for del(5q) in myelodysplasia/acute myeloid leukemia: comparison of EGR1 vs. CSF1R probes and diagnostic yield over metaphase cytogenetics alone.
Sun Y; Cook JR
Leuk Res; 2010 Mar; 34(3):340-3. PubMed ID: 19608274
[TBL] [Abstract][Full Text] [Related]
31. Cryptic deletion of EGR1 in association with a novel balanced t(5;22)(q31;q11.2) in a patient with myelodysplastic syndrome.
Hoffman MW; Janney S; Batanian JR
Cancer Genet Cytogenet; 2009 Jun; 191(2):106-8. PubMed ID: 19446747
[TBL] [Abstract][Full Text] [Related]
32. Hidden chromosome 8 abnormalities detected by FISH in adult primary myelodysplastic syndromes.
Panani AD; Pappa V
In Vivo; 2005; 19(6):979-81. PubMed ID: 16277010
[TBL] [Abstract][Full Text] [Related]
33. Myelodysplastic syndromes associated with interstitial deletion of chromosome 5q: clinicopathologic correlations and new insights from the pre-lenalidomide era.
Holtan SG; Santana-Davila R; Dewald GW; Khetterling RP; Knudson RA; Hoyer JD; Chen D; Hanson CA; Porrata L; Tefferi A; Steensma DP
Am J Hematol; 2008 Sep; 83(9):708-13. PubMed ID: 18634051
[TBL] [Abstract][Full Text] [Related]
34. Several chromosomes involved in translocations with chromosome 5 shown with fluorescence in situ hybridization in patients with malignant myeloid disorders.
Bram S; Rödjer S; Swolin B
Cancer Genet Cytogenet; 2004 Nov; 155(1):74-8. PubMed ID: 15527906
[TBL] [Abstract][Full Text] [Related]
35. Is FISH a relevant prognostic tool in myelodysplastic syndromes with a normal chromosome pattern on conventional cytogenetics? A study on 57 patients.
Bernasconi P; Cavigliano PM; Boni M; Calatroni S; Klersy C; Giardini I; Rocca B; Crosetto N; Caresana M; Lazzarino M; Bernasconi C
Leukemia; 2003 Nov; 17(11):2107-12. PubMed ID: 12931223
[TBL] [Abstract][Full Text] [Related]
36. [A comparative study of fluorescence in situ hybridization versus conventional cytogenetics in the detection of clonal aberrations in myelodysplastic syndrome].
Lai YY; Li N; Feng L; Shi Y; Dang H; He Q; Wang Z; Wang XY; Li Y; Liu Q; Huang XJ
Zhonghua Yi Xue Za Zhi; 2013 Oct; 93(40):3175-9. PubMed ID: 24405535
[TBL] [Abstract][Full Text] [Related]
37. Chromosomal aberrations in bone marrow mesenchymal stroma cells from patients with myelodysplastic syndrome and acute myeloblastic leukemia.
Blau O; Hofmann WK; Baldus CD; Thiel G; Serbent V; Schümann E; Thiel E; Blau IW
Exp Hematol; 2007 Feb; 35(2):221-9. PubMed ID: 17258071
[TBL] [Abstract][Full Text] [Related]
38. Clinical and experimental study of two cases of myelodysplastic syndrome with t(3; 5) (q25; q34) translocation.
Wu Y; Xue Y; Zhao M; Chen S; Pan J; Lu D
Zhonghua Xue Ye Xue Za Zhi; 2002 Jun; 23(6):304-6. PubMed ID: 12411061
[TBL] [Abstract][Full Text] [Related]
39. Chromosome 5q deletion and epigenetic suppression of the gene encoding alpha-catenin (CTNNA1) in myeloid cell transformation.
Liu TX; Becker MW; Jelinek J; Wu WS; Deng M; Mikhalkevich N; Hsu K; Bloomfield CD; Stone RM; DeAngelo DJ; Galinsky IA; Issa JP; Clarke MF; Look AT
Nat Med; 2007 Jan; 13(1):78-83. PubMed ID: 17159988
[TBL] [Abstract][Full Text] [Related]
40. Do we need to do fluorescence in situ hybridization analysis in myelodysplastic syndromes as often as we do?
Costa D; Valera S; Carrió A; Arias A; Muñoz C; Rozman M; Belkaid M; Coutinho R; Nomdedeu B; Campo E
Leuk Res; 2010 Nov; 34(11):1437-41. PubMed ID: 20226525
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]